Crossmark

Bioinformatics-based identification of mirdametinib as a potential therapeutic target for idiopathic pulmonary fibrosis associated with endoplasmic reticulum stress

Crossref DOI link: https://doi.org/10.1007/s00210-025-04076-0

Published Online: 2025-03-28

Published Print: 2025-09

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Chen, Junwei

Du, Yuhan

Yu, Qi

Liu, Dongyu

Zhang, Jinming

Luo, Tingyue

Huang, Haohua

Cai, Shaoxi

Dong, Hangming
License Information

Text and Data Mining valid from 2025-03-28

Version of Record valid from 2025-03-28
More Information

Article History

Received: 3 January 2025

Accepted: 18 March 2025

First Online: 28 March 2025

Declarations

:

: The Southern Medical University Animal Care and Use Committee granted approval for all animal procedures, which adhered to the established Guidelines for the Care and Use of Laboratory Animals (IACUC-LAC-20240522–008).

: All authors who contributed to this work have given their consent for the publication of this manuscript.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below